BATL strives to enable workforce training alongside global medical regulatory convergence in an effort to assist in accelerated drug approvals and ultimate drug access for patients.
Our diverse, innovative, and globally-recognized experiential learning and credentialing programs offer a neutral platform to train the industry’s workforce while also converging the intricacies of global regulatory considerations for pharmaceutical and biopharmaceutical products. In doing so, we increase the potential of accelerated drug approvals with quality, safety and efficacy at the forefront, thus impacting patients for improved access to medicines worldwide.
WHAT’S IT LIKE WHAT IT’S LIKE TO RUN A LAB THAT CHURNS OUT THOUSANDS OF CORONAVIRUS TEST RESULTS PER DAY?
Under the leadership of Jared Auclair, an associate teaching professor of biotechnology, Northeastern’s Life Science Testing Center at the Innovation Campus in Burlington, Massachusetts, has been processing coronavirus tests around the clock.
Ask about our one-day crash course in Protein Structure Analytics in Developing Biopharmaceuticals.
We are rethinking the way we can keep everyone safe and informed during these unprecedented times. Check back for updated event schedule.
If you have any questions about what we do, our courses, or our global impact, feel free to reach out.
A COMMITMENT TO
Research in biotherapeutics is providing promising and innovative drugs that provide hope to millions of patients around the world. Yet these same drugs may pose risks, especially if the challenges inherent in their production, distribution, and marketing are not properly understood and regulated.
The Center of Excellence for Biotherapeutics at Northeastern University’s Biopharmaceutical Analysis Training Laboratory (BATL) will help build expertise and know-how by bringing together scientists and regulators from around the globe for experiential education in these new technologies.
Northeastern establishes global partnership to improve the quality of medicine
Northeastern has joined with a research and training center in Ireland to prepare the next generation of scientists, engineers, and lab technicians to produce high quality drugs for patients around the world.
They’re ensuring that quality medication gets to the people who need it
BATL is expanding its ability to help people in the pharmaceutical and biotechnology industry navigate this process, with $4.3 million in funding from the Massachusetts Life Sciences Center.
Cannabis Products are Everywhere. But What do they Actually Do?
Researchers at Northeastern University and Loyalist College in Ontario, Canada are teaming up to train graduate students in the analytical techniques required to investigate cannabis.